Biological Implants

Publication Date	January 2008
Publisher	RI Technologies
Product Type	Report
Pages	238
ISBN Number	not applicable
Product Code	RIT00008

Price

£1,935.00
approximately: $3,797 | €2,457

PDF

Order above formats by FAX

Summary

Biological Implants report analyzes the market for biological implant procedures. The total biological implants market is analyzed by tissue/muscle; origin, and mode of administration at global level and for each of the geographic regions - North America, Europe, Asia-Pacific and Rest of World. The biological implants market is segmented by Tissue/Muscle into Soft Tissue, Orthopedic, Cardiovascular and Other (includes Dental, Ophthalmic, and Urologic); by Origin into Allograft, and Xenograft; and by Mode of Administration into Injectable and Surgical. Business profiles of 27 major companies are discussed in the report. The report serves as a guide to global biological implants industry covering 164 companies that are engaged in biological implants€ processing, R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. .Projections and estimates are graphically illustrated by geographic region with exclusive graphical representations provided for 241 exhibits.

Content

I. Scope And Methodology
II. Report Synopsis
- 1. Foreword
  - Biological Implants - A Revolutionary Human Repair Technique
  - Segmentation of Biological Implants
  - Exhibit 1: Segmentation of Global Biological Implants Market by Tissue/Muscle(Soft Tissue, Orthopedic, Cardiovascular, and Other*), by Origin (Allograft and Xenograft) and by Mode of Administration (Injectable and Surgical)
- 2. Global Market Analysis
  - Exhibit 2: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Medical Implants
  - An Overview of Medical Implants
  - History of Implants
  - The Need for a Better Implant
  - Naturally Derived Implants
  - Orbital Implants and Artificial Eyes
  - Artificial Skin
  - Hip Replacement
  - Tissues
  - Animal Tissues
  - Plant Tissues
  - Definitions
  - Implant
  - Transplant
  - Explant
  - Types of Implants
  - Artificial Implants
  - Biological Implants
  - Tissue Engineering
  - Market Analysis by Tissue/Muscle Biological Implants by Geographic Region
  - Soft Tissue
  - Exhibit 3: Soft Tissue Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 4: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Orthopedic Biological Implants
  - Exhibit 5: Orthopedic Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 6: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Cardiovascular Biological Implants
  - Exhibit 7: Cardiovascular Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 8: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Other (Dental, Ophthalmic and Urologic)
  - Exhibit 9: Biological Implants in Other Tissue/Muscle (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 10: Other Tissue/Muscle (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Market Analysis by Origin by Geographic Region
  - Allograft
  - Exhibit 11: Allograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 12: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Xenograft
  - Exhibit 13: Xenograft Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 14: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Market Analysis by Mode of Administration by Geographic Region
  - Injectable Biological Implants
  - Exhibit 15: Injectable Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 16: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Surgical Biological Implants
  - Exhibit 17: Surgical Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 18: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Exhibit 19: List of Major Global Companies
- 3. Regional Market Analysis
  - North America
  - Exhibit 20: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Market Analysis by Tissue / Muscle Biological Implants in North America
  - Soft Tissue Biological Implants
  - Exhibit 21: Soft Tissue Biological Implants (2005-2012) - North American
  - Market Analysis (Current & Future) by Geographic Region for the
  - US and Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 22: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Orthopedic Biological Implants
  - Exhibit 23: Orthopedic Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for the US and Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 24: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Cardiovascular Biological Implants
  - Exhibit 25: Cardiovascular Biological Implants (2005-2012) - North American
  - Market Analysis (Current & Future) by Geographic Region for the US and
  - Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 26: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Other (Dental, Ophthalmic and Urologic)
  - Exhibit 27: Biological Implants in Other Tissue/Muscle (2005-2012) - North American
  - Market Analysis (Current & Future) by Geographic Region for the US and Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 28: Biological Implants in Other Tissue/Muscle (2006, 2009 and 2012) -
  - Percentage Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Market Analysis by Origin in North America
  - Allograft
  - Exhibit 29: Allograft Biological Implants (2005-2012) - North American
  - Market Analysis (Current & Future) by Geographic Region for the US and
  - Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 30: Allograft Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Xenograft
  - Exhibit 31: Xenograft Biological Implants (2005-2012) - North American Analysis (Current & Future) by Geographic Region for the US and Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 32: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Market Analysis by Mode of Administration in North America
  - Injectable Biological Implants
  - Exhibit 33: Injectable Biological Implants (2005-2012) - North American
  - Market Analysis (Current & Future) by Geographic Region for the
  - US and Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 34: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Surgical Biological Implants
  - Exhibit 35: Surgical Biological Implants (2005-2012) - North American
  - Market Analysis (Current & Future) by Geographic Region for the US and
  - Canada in US$ Billion (Graphical Representation Included)
  - Exhibit 36: Surgical Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of North American Market Value by Geographic Region for the US and Canada (Graphical Representation Included)
  - Europe
  - Exhibit 37: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Market Analysis by Tissue / Muscle in Europe
  - Soft Tissue Biological Implants
  - Exhibit 38: Soft Tissue Biological Implants (2005-2012) - European
  - Market Analysis (Current & Future) by Geographic Region for Germany,
  - United Kingdom, France Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 39: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of European Market Value by Geographic Region for Germany,
  - United Kingdom, France, Switzerland and
  - Rest of Europe (Graphical Representation Included)
  - Orthopedic Biological Implants
  - Exhibit 40: Orthopedic Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 41: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of European Market Value by Geographic Region for Germany,
  - United Kingdom, France, Switzerland and
  - Rest of Europe (Graphical Representation Included)
  - Cardiovascular Biological Implants
  - Exhibit 42: Cardiovascular Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 43: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of European Market Value by Geographic Region for Germany,
  - United Kingdom, France, Switzerland and
  - Rest of Europe (Graphical Representation Included)
  - Other (Dental, Ophthalmic and Urologic)
  - Exhibit 44: Biological Implants in Other Tissue / Muscle(2005-2012) -
  - European Market Analysis (Current & Future) by Geographic Region for Germany,
  - United Kingdom, France, Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 45: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) -
  - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and
  - Rest of Europe (Graphical Representation Included)
  - Market Analysis by Origin in Europe
  - Allograft
  - Exhibit 46: Allograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 47: Allograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
  - European Market Value by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe (Graphical Representation Included)
  - Xenograft
  - Exhibit 48: Xenograft Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 49: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe (Graphical Representation Included)
  - Market Analysis by Mode of Administration in Europe
  - Injectable Biological Implants
  - Exhibit 50: Injectable Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 51: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe (Graphical Representation Included)
  - Surgical Biological Implants
  - Exhibit 52: Surgical Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe in US$ Billion (Graphical Representation Included)
  - Exhibit 53: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
  - European Market Value by Geographic Region for Germany, United Kingdom, France,
  - Switzerland and Rest of Europe (Graphical Representation Included)
  - Asia-Pacific
  - Exhibit 54: Biological Implants (2005-2012) -Asia-Pacific Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Market Analysis by Tissue / Muscle in Asia Pacific
  - Soft Tissue Biological Implants
  - Exhibit 55: Soft Tissue Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 56: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific (Graphical Representation Included)
  - Orthopedic Biological Implants
  - Exhibit 57: Orthopedic Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 58: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Asia-Pacific Market Value by Geographic Region for Japan,
  - Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Cardiovascular Biological Implants
  - Exhibit 59: Cardiovascular Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 60: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Asia-Pacific Market Value by Geographic Region for Japan,
  - Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Other (Dental, Ophthalmic and Urologic)
  - Exhibit 61: Biological Implants in Other Tissue / Muscle (2005-2012) - Asia-Pacific
  - Market Analysis (Current & Future) by Geographic Region for Japan,
  - Australia and Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 62: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) -
  - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Market Analysis by Origin in Asia Pacific
  - Allograft Biological Implants
  - Exhibit 63: Allograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 64: Allograft Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Asia-Pacific Market Value by Geographic Region for Japan,
  - Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Xenograft Biological Implants
  - Exhibit 65: Xenograft Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 66: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Asia-Pacific Market Value by Geographic Region for Japan,
  - Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Market Analysis by Mode of Administration in Asia Pacific
  - Injectable Biological Implants
  - Exhibit 67: Injectable Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 68: Injectable Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Asia-Pacific Market Value by Geographic Region for Japan,
  - Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Surgical Biological Implants
  - Exhibit 69: Surgical Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
  - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
  - Exhibit 70: Surgical Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Asia-Pacific Market Value by Geographic Region for Japan,
  - Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Rest of World
  - Exhibit 71: Biological Implants (2005-2012) - Rest of World Market Analysis (Current &
  - Future) for Israel, Brazil and Rest of world in US$ Million (Graphical Representation Included)
  - Market Analysis by Tissue/Muscle in Rest of World
  - Soft Tissue Biological Implants
  - Exhibit 72: Soft Tissue Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and
  - Rest of world in US$ Million (Graphical Representation Included)
  - Exhibit 73: Soft Tissue Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and
  - Rest of World (Graphical Representation Included)
  - Orthopedic Biological Implants
  - Exhibit 74: Orthopedic Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and
  - Rest of world in US$ Million (Graphical Representation Included)
  - Exhibit 75: Orthopedic Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Rest of World Market Value by Geographic Region for Israel,
  - Brazil and Rest of world (Graphical Representation Included)
  - Cardiovascular Biological Implants
  - Exhibit 76: Cardiovascular Biological Implants (2005-2012) -Rest of World Market
  - Analysis (Current & Future) by Geographic Region for Israel, Brazil and
  - Rest of world in US$ Million (Graphical Representation Included)
  - Exhibit 77: Cardiovascular Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Rest of World Market Value by Geographic Region for Israel,
  - Brazil and Rest of World (Graphical Representation Included)
  - Other (Dental, Ophthalmic and Urologic)
  - Exhibit 78: Biological Implants in Other Tissue / Muscle (2005-2012) -Rest of World
  - Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and
  - Rest of world in US$ Million (Graphical Representation Included)
  - Exhibit 79: Biological Implants in Other Tissue / Muscle (2006, 2009 and 2012) -
  - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World (Graphical Representation Included)
  - Market Analysis by Origin in Rest of World
  - Allograft Biological Implants
  - Exhibit 80: Allograft Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and
  - Rest of world in US$ Million (Graphical Representation Included)
  - Exhibit 81: Allograft Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Rest of World Market Value by Geographic Region for Israel,
  - Brazil and Rest of World (Graphical Representation Included)
  - Xenograft Biological Implants
  - Exhibit 82: Xenograft Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and
  - Rest of world in US$ Million (Graphical Representation Included)
  - Exhibit 83: Xenograft Biological Implants (2006, 2009 and 2012) - Percentage
  - Breakdown of Rest of World Market Value by Geographic Region for Israel,
  - Brazil and Rest of World (Graphical Representation Included)
  - Market Analysis by Mode of Administration in Rest of World
  - Injectable Biological Implants
  - Exhibit 84: Injectable Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 85: Injectable Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and
  - Rest of World (Graphical Representation Included)
  - Surgical Biological Implants
  - Exhibit 86: Surgical Biological Implants (2005-2012) -Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 87: Surgical Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel,
  - Brazil and Rest of World (Graphical Representation Included)
III. Product/Technology Research
- 1. Introduction
  - Biological Implants Growth Trends - Global Markets
  - Exhibit 88: Global Market for Biological Implants: Geographic Regions (North America,
  - Europe, Asia-Pacific, Rest of World) Ranked by Projected CAGR for
  - 2005 through 2012(Graphical Representation Included)
  - Types of Biological Implants
  - Application Biological Implants
  - Function and Use of Biological Implants
  - Application of Biological Implants in ENT surgery
  - Location of the Bioimplant: Middle Ear
  - Ossicle Replacement Draws Mixed Response
  - Tympanoplasty
  - Traumatic Perforation Using Fibrin-coated Collagen
  - Location of the Bioimplant: Paranasal Sinuses and Cranial Bones
  - Orbital Wall Reconstructions Using Allogenic Materials
  - Location of the Bioimplant: Bone and Cartilage of the Nose
  - Allogenic Materials to Develop Cartilage
  - Septal Abscess
  - Soft Tissue Implants
  - Location of the Bioimplant: Base of the Skull
  - Allogenic Materials to Treat Dural Defects
  - Allogenic Materials Required to Accomplish Duraplasty
  - The Application of Fibrin Glues in ENT Surgeries
  - Location of the Bioimplant: Trachea/Larynx
  - The Replacement of Trachea Using Solvent-preserved Allogenic Variety of Trachea
  - The Various Disorders of Vocal Cord
  - Location of the Bioimplant: Skin
  - The Process of Skin Replacement
  - Wrinkle Lift Treatment
- 2. Segmentation of Biological Implants
  - Segmentation by Tissue/Muscle
  - Growth Trends - Global Market for Biological Implants by Tissue /Muscle
  - Exhibit 89: Global Market for Biological Implants by Tissue / Muscle (Soft Tissue,
  - Orthopedic, Cardiovascular, Other) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  - Soft Tissue Biological Implants
  - Growth Trends - Global Market for Soft Tissue Biological Implants
  - Exhibit 90: Global Market for Soft Tissue Biological Implants: Geographic Regions (North America, Europe, Asia- Pacific, Rest of World) Ranked by projected
  - CAGR for 2005 through 2012 (Graphical Representation Included)
  - Biological Implants in Cosmetic Surgery
  - Lip Augmentation Using Bioimplants
  - Allograft Implants Used in Lip Augmentation
  - Types and Characteristics of Various Allograft Implants
  - Alloderm
  - Apligraft
  - Cosmoderm 1 & 2
  - Cosmoplast
  - Cymetra or Micronized Alloderm
  - Fascian
  - Surgisis Soft Tissue Graft & Surgisis ES Soft Tissue Graft
  - Self Derived [Autologous] Implants & Injectables
  - Types and Characteristics of Autologous Implants
  - Autologen
  - Dermis Grafts
  - Dermis Fat Grafts
  - Fascia Grafts
  - Fat Grafting, Transfer or Transplanting
  - Isolagen
  - Scar Tissue Grafting
  - Tendon Grafting
  - Cosmetic Surgery
  - Global Market Analysis for Cosmetic Surgery
  - Exhibit 91: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 92: Cosmetic Surgery (2005-2012) - Global Market Analysis (Current & Future) for Cosmetic Surgery in US, Europe, Asia, and
  - Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 93: Cosmetic Surgery (2006, 2009 and 2012) - Percentage Breakdown for
  - Cosmetic Surgery in US, Europe, Asia - Pacific, and
  - Rest of World (Graphical Representation Included)
  - Orthopedic Biological Implants
  - Growth Trends - Global Market for Orthopedic Biological Implants
  - Exhibit 94: Global Market for Orthopedic Biological Implants : Geographic Regions (North America, Europe, Asia- Pacific, Rest of World) Ranked by Projected
  - CAGR for 2005 through 2012 (Graphical Representation Included)
  - Bone Graft Substitutes
  - Osteoinductive Agents - Substitute for Bone Allografts
  - Fibrin Matrix
  - Cardiovascular Biological Implants
  - Growth Trends - Global Market for Cardiovascular Biological Implants
  - Exhibit 95: Global Market for Cardiovascular Biological Implants : Geographic Regions (North America, Europe, Asia- Pacific, Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  - Other (Dental, Ophthalmic, Urologic)
  - Growth Trends - Global Market for Biological Implants in other Tissue/Muscle
  - Exhibit 96: Global Market for Biological Implants in other Tissue/Muscle: Geographic Regions (North America, Europe, Asia-Pacific, and Rest of World) Ranked by
  - Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  - Other Tissue/Muscle Biological Implant Products
  - Ophthalmic Biological Implants
- 3. Segmentation by Origin of Biological Implants
  - Growth Trends - Global Market for Biological Implants by Origin
  - Exhibit 97: Global Market for Biological Implants by Origin (Allograft, Xenograft)
  - Geographic Regions (North America, Europe, Asia-Pacific, and Rest of World) Ranked by
  - Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  - Allograft and Xenograft Biological Implants
  - Autografts and their Limitations
  - Utilization of the Allograft Bone Tissue
  - Limitations of the Process
  - Few Disadvantages of Using Allografts
  - Preventive Measures for Warding Infection
  - Bone Grafting
  - Xenografts
  - Using Valved Porcine Xenografts in the Right Ventricle Outlet for Congenital Anomalies
  - Other Avenues of Research
  - The L-Hydro Method
  - Allograft Biological Implants
  - Growth Trends - Global Market for Allograft Biological Implants
  - Exhibit 98: Global Market for Allograft Biological Implants : Geographic Regions (North America, Europe, Asia-Pacific, and Rest of World) Ranked by Projected
  - CAGR for 2005 through 2012 (Graphical Representation Included)
  - Xenograft Biological Implants
  - Growth Trends - Global Market for Xenograft Biological Implants
  - Exhibit 99: Global Market for Xenograft Biological Implants : Geographic Regions (North America, Europe, Asia-Pacific, and Rest of World) Ranked by Projected
  - CAGR for 2005 through 2012 (Graphical Representation Included)
  - Allograft Bone Tissue - Processing
  - Preparation for Biotransplantation
  - Allograft Bone Tissue
  - Base Tissue Segment
  - The Processing of Allograft Bone Tissue
  - Processing of Grafton DBM - A Biological Implant Product of Osteotech
  - CXC Technology
  - The Process of Tissue Processing Using Tutogen
  - The Process of Manufacture and Processing of Allografts
  - Stentless Porcine Xenograft (Mitral Valve Replacement)
- 4. Segmentation by Mode of Administration
  - Growth Trends - Global Market for Biological Implants by Mode of Administration
  - Exhibit 100: Global Market for Biological Implants by Mode of Administration (Injectable ,
  - Surgical) : Geographic Regions (North America, Europe, Asia-Pacific, and Rest of World)
  - Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  - Injectable Biological Implants
  - Growth Trends - Global Market for Injectable Biological Implants
  - Exhibit 101: Global Market for Biological Implants by Mode of Administration : Geographic
  - Regions (North America, Europe, Asia-Pacific, and Rest of World) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
  - Injectable Fillers for Soft Tissue Augmentation
  - Types of Augmentation Materials
  - Osteogenic Injectable Bone Substitutes
  - Surgical Biological Implants
  - Growth Trends - Global Market for Surgical Biological Implants
  - Exhibit 102: Global Market for Surgical Biological Implants : Geographic Regions (North America, Europe, Asia-Pacific, and Rest of World) Ranked by Projected
  - CAGR for 2005 through 2012 (Graphical Representation Included)
- 5. Product Trends
  - Research and Development
  - Neovascularisation Promoting Membrane for Biological Implants
  - Biological Implants of Semipermeable Amphiphilic Membranes
  - Artificial Tissue Systems
  - Stem Cells in Biological Implants
  - The Journey of Embryonic Stem Cells from Fundamental Biology to Medicine
  - Application of Umbilical Cord Lining Cells as Therapeutic Bioimplants for Metabolic Disorders
  - Drug Delivery and Smart Biological Implants
  - Tissue Engineered Biological Implants
  - Biological Implants Treatment of Vocal Fold Disorders
  - Systemic Inhibition of Tumor Growth using Biological Implants
  - Process of Secretion and Expression of TSP-2 using Polymer-Cell Grafts in Vivo
  - Inhibition of Tumor Growth in Mice Containing TSP-2-secreting Bioimplants.
  - Inhibition of Tumor Angiogenesis in Mice Containing TSP-2-secreted Bioimplants
  - Surgery for Valvular Heart Disease
  - RVOT Reconstruction
  - Bovine Valved Venous Xenografts for RVOT Reconstruction
  - Alloplastic Implants for Treatment of Stress Urinary Incontinence
  - Repair of Cartilage Lesions
  - Repair of Cartilage Lesions Using Biological Implants - A Comparative Histological and
  - Biomechanical Study in Goats
  - Cryopreservation of Human Ovarian Tissues
  - ADAPT (Advanced Tissue Process) - CXC Technology
  - Clinical Trials
  - Man Implanted with Teeth obtained from shoulder!!!!
  - Implantation of Esterified Hyaluronic Acid in Microdissected Reinke€s Space
  - Healing of Brain and Bones
  - Saving Brain and Spines
  - The Perfect Knee
  - Get the Smile Back on Your Face
  - Mending Broken Hearts
  - Biological Implants in Sports Medicine
  - Allografts in Sports
  - Transplantation Genetics
  - Acceptance of Biological Implants
  - Biphasic Implants
  - Preparation of a Biphasic Scaffold
  - Devising Biological Implants for Healing of Joint Disorders
  - Biomaterials
  - The Construction of New Body Parts
  - Orthopedic Biomaterials
  - Heart Valve Biomaterials
  - Risk of Infection, Off - Label Use and Safety
  - Different Processes Used for Preservation of Allografts and Xenografts
  - Ethical Issues Concerning Biological Implants
  - Moral Issue and Balancing Concept
  - Animal Rights
  - Rights
  - Objectivity
  - Practical Issue
  - Animal-to-Human Transplantation
IV. Market Dynamics
- 1. Market Overview
  - Global Market Analysis for Implants
  - Exhibit 103: Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Global Market Analysis for Spinal Implants
  - Exhibit 104: Spinal Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 105: Implants (2005-2012) - Global Market Analysis (Current & Future) for Implants in US, Europe, Asia, Canada and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 106: Implants (2006, 2009 and 2012) - Percentage Breakdown for Implants in USA, Europe, Asia-Pacific, Canada and Rest of World (Graphical Representation Included)
  - Global Market Analysis for Orthopedic Implants
  - Exhibit 107: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 108: Orthopedic Implants (2005-2012) - Global Market Analysis (Current & Future) for Orthopedic Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 109: Orthopedic Implants (2006, 2009 and 2012) - Percentage Breakdown for Orthopedic Implants in USA, Europe, Asia - Pacific, and
  - Rest of World (Graphical Representation Included)
  - Global Market Analysis for Cardiovascular Implants
  - Exhibit 110: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 111: Cardiovascular Implants (2005-2012) - Global Market Analysis (Current &
  - Future) for Cardiovascular Implants in US, Europe, Asia, and
  - Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 112: Cardiovascular Implants (2006, 2009 and 2012) - Percentage Breakdown for Cardiovascular Implants in USA, Europe, Asia - Pacific, and
  - Rest of World (Graphical Representation Included)
  - Global Market Analysis for Dental Implants
  - Exhibit 113: Dental Implants (2005-2012) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 114: Dental Implants (2005-2012) - Global Market Analysis (Current &
  - Future) for Dental Implants in US, Europe, Asia, and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 115: Dental Implants (2006, 2009 and 2012) - Percentage Breakdown for Dental Implants in US, Europe, Asia - Pacific, and Rest of World (Graphical Representation Included)
  - Global Market Analysis for Biological Implants
  - Exhibit 116: Biological Implants (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific, and
  - Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 117: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
  - Global Market Value by Geographic Region for North America, Europe,
  - Asia-Pacific, Rest of World (Graphical Representation Included)
  - Exhibit 118: Biological Implants (2005-2012): Global Market Analysis by Tissue/
  - Muscle (Soft Tissue, Orthopedic, Cardiovascular, Others) (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 119: Biological Implants (2005-2012): Global Market Analysis by Origin (Allograft and Xenograft) (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 120: Biological Implants (2005-2012): Global Market Analysis by Mode of Administration (Injectable and Surgical)(Current & Future) in US$ Billion (Graphical Representation Included)
- 2. Market Trends
- 3. Major Companies in Biological Implants Industry
  - Aastrom Biosciences, Inc. (USA)
  - Alphatec Spine, Inc. (USA)
  - Arthro-Kinetics Plc (UK)
  - Asterand Plc (UK)
  - AutoTissue GmbH (Germany)
  - bioMD Limited (Australia)
  - BioTissue Technologies AG (Germany)
  - CONMED Linvatec (USA)
  - CryoLife, Inc. (USA)
  - Curis, Inc. (USA)
  - Exactech, Inc. (USA)
  - Fascia Biosystems LLC (USA)
  - Inamed Aesthetics (USA)
  - Inion OY (Finland)
  - IOP, Inc. (USA)
  - IsoTis Inc. (USA)
  - LifeCell Corporation (USA)
  - Maxigen Biotech, Inc. (Taiwan)
  - NuVasive Inc. (USA)
  - Organogenesis, Inc. (USA)
  - Osteotech, Inc. (USA)
  - OsteoBiologics, Inc. (USA)
  - Pegasus Biologics, Inc. (USA)
  - QLT, Inc. (Canada)
  - Regeneration Technologies, Inc. (USA)
  - Stryker Corporation (USA)
  - Tutogen Medical, Inc. (USA)
- 4. Major Activities in Biological Implants Industry
  - Inion Granted with US Patent for Bioactive Materials Technology
  - Tutogen Medical Signs an International Distribution Agreement with Coloplast Corporation
  - Osteotech and Novation sign Single Source Agreement
  - Aastrom€s IND Phase III bags FDA approval for Treating Osteonecrosis of the Femoral Head
  - ACT Uses Hemangioblasts to Reduce the Risk of Heart Attack
  - Alphatec Holdings Acquires Technology License for Minimally Invasive
  - Spinal Surgery
  - Japanese Ministry Endorses Alphatec€s NOVEL Titanium Product Family
  - FDA Approval to Exactech for Distribution of Equinox Reverse Shoulder
  - Advanced Cell Technology Buys Technology Assets of Infigen
  - Bone Regeneration Phase II Clinical Trials Initiated by Kuros
  - FDA grants Orphan Drug Designation to Kuros€ New Bone Repair Product
  - Inion Product Range of BMI Widens with the Approval of ANCHRON in Europe
  - NuVasive Buys Biologic Product Platform
  - License Agreements between Alphatec and Scient€x for Manufacture and
  - Distribution of Spine Implants
  - University of Rochester and StemCapture Unveil an Anticancer
  - Stem Cell Implant Device.
  - Musculoskeletal Transplant Foundation Announces Three Year Deal with Strategic Alliance
  - Bioheart Inc. to Expand Clinical Trials of Adult Myogenic Stem Cells
  - Encore Medical Acquires Cefar AB of Sweden
  - Pegasus Biologics€ Wound Dressing Receives FDA Approval
  - CryoLife Enters into Alliance with Bioform Medical for Development and
  - Marketing of BioGlue
  - Stem Cell Innovations Enters into Collaboration with ND TWente University for Assessment of Bone Forming Capability of Pluricells
  - Exactech Gains FDA Clearance for DBM with Bone Chips, OptecureTM +CCC
  - Affinergy Signs Development Agreement with Synthes
  - Affinergy Joins Hands with DuPont for New Bio-based Materials
  - Acquisition of Exclusive Option Rights of Cell Technology by Bioheart
  - Axordia Enters into Collaboration with Lombard Medical Technologies for Developing of
  - Therapy for Coronary Artery Disease
  - Acologix Announces Findings of the Initial Feasibility Study of AC-100
  - Bone Growth Stimulator - New Product of Alphatec Holdings.
  - Exactech Adds Cemented Stem to its Hip System
  - Avecia Given 1m Grant to Develop Bioprocessing Technology for
  - Generating Synthetic Skin for Burn Victims
  - Patent Licensing Agreement Signed between Bioheart and Tricardia
  - Inion€s Novel Bioactive Technology Granted with US Patent
  - Cytori Reveals Outcome of Adipose-derived Stem Cell Therapy
  - Alphatec Spine and OsteoBiologics Enter into an Agreement for
  - Distribution of Spine Products.
  - Bioheart Signs Agreement to Use Cleveland Clinic€s Proprietary Methods
  - Pegasus Launches OrthADAPT Bioimplant - a Revolutionary New Biologic Scaffold for Orthopedic Soft Tissue Reinforcement
  - Cambrex Buys Cutanogen Corporation
  - Inion Enters into Alliance with Aesculap for Distribution of its Spinal Product Range Across the US and Canada
  - Inion Enters into an Agreement with the University of Cambridge for Advancement of
  - Bioactive Products
  - Total ReCord Initiates Novel treatment for Spinal Cord Injuries
  - Inion and Richard Wolf Medical Instruments Enter into Agreement for
  - Distribution of Sports Medicine
  - International Distribution Agreement Signed by OsteoBiologics and CONMED Linvatec for
  - Cartilage and Bone Repair Product Range
  - Millenium Biologix Enters into License Agreement Exclusively to Improve ACTES(TM)-C
  - Inion Launches Biodegradable Spinal Implant in the EU
  - OsteoBiologics Enters into Collaboration with Nexa Orthopedics for Surgical Extremities
  - Affinergy Awarded SBIR Grant for Research on Medical Device Materials
  - Genzyme Acquires Verigen AG
  - CryoLife and Endologix Enter into a Development Agreement for BioFoam
- 5. Regional Market Analysis
  - A. NORTH AMERICA
    - Market Analysis
    - Exhibit 121: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    - Market Analysis by Geographic Region
    - Exhibit 122: Biological Implants (2005-2012) -North American Market Analysis (Current & Future) by Geographic Region for the US and
    - Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 123: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - North American Market Value by Geographic Region for the US and
    - Canada (Graphical Representation Included)
    - Analysis by Tissue/Muscle
    - Exhibit 124: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Tissue/Muscle for ( Soft Tissue, Orthopedic,
    - Cardiovascular, Other) in US$ Billion (Graphical Representation Included)
    - Exhibit 125: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North
    - American Market Value by Tissue/Muscle for Soft Tissue, Orthopedic,I Cardiovascular, and Other (Dental, Ophthalmic, Urologic) (Graphical Representation Included)
    - Analysis by Origin
    - Exhibit 126: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Origin ( Allograft, Xenograft) in US$ Billion (Graphical Representation Included)
    - Exhibit 127: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Origin for Allograft and
    - Xenograft (Graphical Representation Included)
    - Analysis by Mode of Administration
    - Exhibit 128: Biological Implants (2005-2012) - North American Market Analysis (Current & Future) by Mode of Administration ( Injectable, Surgical ) in US$ Billion (Graphical Representation Included)
    - Exhibit 129: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - North American Market Value by Mode of Administration for Injectable and Surgical (Graphical Representation Included)
    - North American Biological Implants Market By Country
    - A1. United States
    - United States Market Analysis
    - Analysis by Tissue/Muscle
    - Exhibit 130: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Tissue/Muscle for ( Soft Tissue, Orthopedic,
    - Cardiovascular, Other) in US$ Billion (Graphical Representation Included)
    - Exhibit 131: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the US Market Value by Tissue/Muscle for Soft Tissue, Orthopedic,
    - Cardiovascular, and Other (Dental, Ophthalmic, Urologic)
    - Analysis by Origin
    - Exhibit 132: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Origin ( Allograft, Xenograft) in US$ Billion (Graphical Representation Included)
    - Exhibit 133: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the US Market Value by Origin for Allograft and
    - Xenograft (Graphical Representation Included)
    - Analysis by Mode of Administration
    - Exhibit 134: Biological Implants (2005-2012) -The US Market Analysis (Current & Future) by Mode of Administration (Injectable, Surgical) in US$ Billion (Graphical Representation Included)
    - Exhibit 135: Biological Implants (2006, 2009 and 2012) - Percentage
    - Breakdown of the US Market Value by Mode of Administration for
    - Injectable and Surgical (Graphical Representation Included)
    - A2. Canada
    - Canadian Market Analysis
    - Analysis by Tissue/Muscle
    - Exhibit 136: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Tissue/Muscle for ( Soft Tissue, Orthopedic,
    - Cardiovascular, Other) in US$ Billion (Graphical Representation Included)
    - Exhibit 137: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the
    - Canadian Market Value by Tissue/Muscle for Soft Tissue, Orthopedic,
    - Cardiovascular, and Other (Dental, Ophthalmic, Urologic)
    - Analysis by Origin
    - Exhibit 138: Biological Implants (2005-2012) - Canadian Market Analysis (Current & Future) by Origin ( Allograft, Xenograft) in US$ Billion (Graphical Representation Included)
    - Exhibit 139: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Origin for Allograft and
    - Xenograft (Graphical Representation Included)
    - Analysis by Mode of Administration
    - Exhibit 140: Biological Implants (2005-2012) -Canadian Market Analysis (Current & Future) by Mode of Administration (Injectable, Surgical) in US$ Billion (Graphical Representation Included)
    - Exhibit 141: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of the Canadian Market Value by Mode of Administration for Injectable and Surgical (Graphical Representation Included)
  - B. EUROPE
    - Market Analysis
    - Exhibit 142: Biological Implants (2005-2012) - European Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    - Market Analysis by Geographic Region
    - Exhibit 143: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and
    - Rest of Europe in US$ Billion (Graphical Representation Included)
    - Exhibit 144: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - European Market Value by Geographic Region for Germany, United Kingdom,
    - France, Switzerland and Rest of Europe (Graphical Representation Included)
    - Analysis by Tissue/Muscle
    - Exhibit 145: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Tissue/Muscle for Soft Tissue, Orthopedic, Cardiovascular and Other (Dental,
    - Ophthalmic, Urologic) in US$ Billion (Graphical Representation Included)
    - Exhibit 146: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - European Market Value by Tissue/Muscle for Soft tissue, Orthopedic, Cardiovascular, and Other (Dental, Ophthalmic, Urologic) (Graphical Representation Included)
    - Analysis by Origin
    - Exhibit 147: Biological Implants (2005-2012) - European Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Billion (Graphical Representation Included)
    - Exhibit 148: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Origin for Allograft and
    - Xenograft (Graphical Representation Included)
    - Analysis by Mode of Administration
    - Exhibit 149: Biological Implants (2005-2012) -European Market Analysis (Current &
    - Future) by Mode of Administration (Injectable, Surgical) in US$ Billion (Graphical Representation Included)
    - Exhibit 150: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Mode of Administration for
    - Injectable and Surgical (Graphical Representation Included)
    - European Biological Implants Market By Country
    - B1. Germany
    - B2. The United Kingdom
    - B3. France
    - B4. Switzerland
    - B5. Rest of Europe
  - C. ASIA-PACIFIC
    - Market Analysis
    - Exhibit 181: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    - Analysis by Geographic Region
    - Exhibit 182: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, Australia and
    - Rest of Asia-Pacific in US$ Billion (Graphical Representation Included)
    - Exhibit 183: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - Asia-Pacific Market Value by Geographic Region for Japan, Australia and
    - Rest of Asia-Pacific (Graphical Representation Included)
    - Analysis by Tissue/Muscle
    - Exhibit 184: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Tissue/Muscle for Soft tissue, Orthopedic,
    - Cardiovascular and Other (Dental, Ophthalmic, Urologic) in US$ Billion (Graphical Representation Included)
    - Exhibit 185: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Tissue/Muscle for Soft tissue,
    - Orthopedic, Cardiovascular and Other (Dental, Ophthalmic,
    - Urologic) (Graphical Representation Included)
    - Analysis by Origin
    - Exhibit 186: Biological Implants (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Billion (Graphical Representation Included)
    - Exhibit 187: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Origin for Allograft and
    - Xenograft (Graphical Representation Included)
    - Analysis by Mode of Administration
    - Exhibit 188: Biological Implants (2005-2012) -Asia Pacific Market Analysis (Current & Future) by Mode of Administration for Injectable and Surgical in US$ Billion (Graphical Representation Included)
    - Exhibit 189: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Asia Pacific Market Value by Mode of Administration for Injectable and
    - Surgical (Graphical Representation Included)
    - Asia-Pacific Biological Implants Market By Country
  - C1. Japan
    - Market Analysis
    - Analysis by Tissue/Muscle
    - Exhibit 190: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Tissue/Muscle for Soft Tissue, Orthopedic,
    - Cardiovascular and Other (Dental, Ophthalmic, Urologic) in US$ Billion (Graphical Representation Included)
    - Exhibit 191: Biological Implants (2006, 2009 and 2012) - Percentage
    - Breakdown of Japanese Market Value by Tissue/Muscle for Soft Tissue,
    - Orthopedic, Cardiovascular and
    - Other (Dental, Ophthalmic, Urologic)
    - Analysis by Origin
    - Exhibit 192: Biological Implants (2005-2012) - Japanese Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Billion (Graphical Representation Included)
    - Exhibit 193: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Origin for Allograft and
    - Xenograft (Graphical Representation Included)
    - Analysis by Mode of Administration
    - Exhibit 194: Biological Implants (2005-2012) -Japanese Market Analysis (Current &
    - Future) by Mode of Administration for Injectable and Surgical in US$ Billion (Graphical Representation Included)
    - Exhibit 195: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Mode of Administration for Injectable and
    - Surgical (Graphical Representation Included)
    - C2. Australia
    - C3. Rest of Asia-Pacific
  - D. REST OF WORLD
    - Market Analysis
    - Exhibit 208: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    - Analysis by Geographic Region
    - Exhibit 209: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and
    - Rest of world in US$ Million (Graphical Representation Included)
    - Exhibit 210: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - Rest of World Market Value by Geographic Region for Israel,
    - Brazil and Rest of world (Graphical Representation Included)
    - Analysis by Tissue/Muscle
    - Exhibit 211: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Tissue/Muscle for Soft Tissue, Orthopedic,
    - Cardiovascular and Other (Dental, Ophthalmic, Urologic) in US$ Million (Graphical Representation Included)
    - Exhibit 212: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - Rest of World Market Value by Tissue/Muscle for Soft Tissue, Orthopedic,
    - Cardiovascular and Other (Dental, Ophthalmic, Urologic) (Graphical Representation Included)
    - Analysis by Origin
    - Exhibit 213: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Origin for Allograft and Xenograft in US$ Million (Graphical Representation Included)
    - Exhibit 214: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Origin for Allograft and
    - Xenograft (Graphical Representation Included)
    - Analysis by Mode of Administration
    - Exhibit 215: Biological Implants (2005-2012) - Rest of World Market Analysis (Current & Future) by Mode of Administration for Injectable and Surgical in US$ Million (Graphical Representation Included)
    - Exhibit 216: Biological Implants (2006, 2009 and 2012) - Percentage Breakdown of
    - Rest of World Market Value by Mode of Administration for Injectable and
    - Surgical (Graphical Representation Included)
    - Rest of World Biological Implants Market By Country
    - D1. Israel
    - D2.Brazil
    - D3. Rest of World (Excluding Israel and Brazil)
- 6. Biological Implants - The Industry Outlook
V. Corporate Directory